Comprehensive analysis identifies CLEC1B as a potential prognostic biomarker in hepatocellular carcinoma

Qiangan Jing,Chen Yuan,Chaoting Zhou,Weidong Jin,Aiwei Wang,Yanfang Wu,Wenzhong Shang,Guibing Zhang,Xia Ke,Jing Du,Yanchun Li,Fangchun Shao
DOI: https://doi.org/10.1186/s12935-023-02939-1
IF: 6.429
2023-06-13
Cancer Cell International
Abstract:C-type lectin domain family 1 member B (CLEC1B, encoding the CLEC-2 protein), a member of the C-type lectin superfamily, is a type II transmembrane receptor involved in platelet activation, angiogenesis, and immune and inflammatory responses. However, data regarding its function and clinical prognostic value in hepatocellular carcinoma (HCC) remain scarce.
oncology
What problem does this paper attempt to address?